Hospitalization cost reduction with sacubitril-valsartan implementation in a cohort of patients from the Daunia Heart Failure Registry

INTRODUCTION: Aim of this study was to assess the impact of the introduction of new class of drugs (ARNI: angiotensin receptor-neprilysin inhibitor) on hospital related costs in a real world cohort of patients with chronic heart failure (CHF). METHODS: Seventy-three consecutive patients with CHF and...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Int J Cardiol Heart Vasc
मुख्य लेखकों: Correale, Michele, Monaco, Ilenia, Ferraretti, Armando, Tricarico, Lucia, Padovano, Giuseppina, Formica, Ennio Sascia, Tozzi, Valeria, Grazioli, Davide, Di Biase, Matteo, Brunetti, Natale Daniele
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Elsevier 2019
विषय:
Original Paper
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437279/
https://ncbi.nlm.nih.gov/pubmed/30963090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2018.12.009
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन